BLACK DIAMOND THERAPEUTICS - FDA MEETING SUPPORTS PIVOTAL DEVELOPMENT AND POTENTIAL ACCELERATED APPROVAL BASED ON CNS-ORR - SEC FILING

Reuters · 2d ago

Please log in to view news